SCHEMBL6154433

SCHEMBL6154433

NC(=O)c1ccc(NC2CCCN(Cc3ccccc3)CC2)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 2/20 0.61
GAA P10253 1/20 0.60
ROCK2 O75116 3/20 0.57
KCNH2 Q12809 1/20 0.56
SIGMAR1 Q99720 3/20 0.52
TMEM97 Q5BJF2 2/20 0.52
DRD4 P21917 2/20 0.52
KMT2A Q03164 2/20 0.52
SLC6A12 P48065 2/20 0.52
DRD2 P14416 1/20 0.52
DRD3 P35462 1/20 0.52
MCHR1 Q99705 1/20 0.52
CYP1A2 P05177 1/20 0.52
CYP3A4 P08684 1/20 0.52
CYP2D6 P10635 1/20 0.52
CYP2C9 P11712 1/20 0.52
TSHR P16473 1/20 0.52
MAPK1 P28482 1/20 0.52
CYP2C19 P33261 1/20 0.52
DPP7 Q9UHL4 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6153555 0.95 LTA4H (0.66) LTA4HGAAROCK2KCNH2SIGMAR1
Hydrochloric Acid SCHEMBL6157025 0.94 LTA4H (0.65) LTA4HGAAROCK2KCNH2SIGMAR1
SCHEMBL6153437 0.91 ROCK2 (0.60) LTA4HGAAROCK2KCNH2DRD4
SCHEMBL6156841 0.88 GAA (0.59) LTA4HGAAROCK2KCNH2SIGMAR1
SCHEMBL4229314 0.85 LTA4H (0.80) LTA4HROCK2KCNH2SIGMAR1TMEM97
SCHEMBL6153280 0.84 OPRK1 (0.55) GAAROCK2KCNH2SIGMAR1DRD4
SCHEMBL8070227 0.81 ALDH1A1 (0.68) LTA4HGAASIGMAR1KMT2AMCHR1
SCHEMBL6154970 0.80 MCHR1 (0.56) ROCK2KCNH2SIGMAR1DRD4SLC6A12
SCHEMBL23805141 0.80 KMT2A (0.66) LTA4HGAAROCK2SIGMAR1DRD4
SCHEMBL6154132 0.80 POLB (0.56) LTA4HGAAROCK2KCNH2SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050182040-A1 Benzamide derivatives DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2005-08-18 US disclosed
EP-1500643-A1 BENZAMIDE DERIVATIVES SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 2005-01-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050182040-A1 Benzamide derivatives ROCK1, ROCK2, NHERF1 LTA4H 1043/4885GAA 2875/4885ROCK2 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.